000 | 01048nam a2200361#i 4500 | ||
---|---|---|---|
001 | 0000014430 | ||
003 | NIH | ||
005 | 20240220144534.0 | ||
008 | 240220s2007 xx 000 0 eng d | ||
020 | _a9781588295279 | ||
040 |
_aIMR _erda |
||
041 | _aeng | ||
060 | _aQZ202 | ||
090 |
_aQZ202 _bapo 2007 |
||
245 | 0 |
_aApoptosis, senescence, and cancer/ _cedited by David A. Gewirtz, Shawn E. Holt, Steven Grant |
|
250 | _a2nd ed | ||
264 | 1 |
_aTotowa, New Jersey: _bHumana Press, _c2007 |
|
300 |
_axvii, 599 pages: _billustration(some col.) _c26cm |
||
336 |
_atext _2rdacontent |
||
337 |
_aunmediated _2rdamedia |
||
338 |
_avolume _2rdacarrier |
||
490 | _aCancer drug discovery and development | ||
650 | 1 | 0 | _aApoptosis |
650 | 2 | 0 |
_aCell Aging _xdrug effects |
650 | 2 | 0 | _aCell Transformation, Neoplastic |
650 | 2 | 0 | _aDNA Damage |
650 | 2 | 0 | _aGenomic Instability |
650 | 2 | 0 |
_aNeoplasms _xdrug therapy |
700 | _aGewirtz, David A. | ||
700 | _aGrant, Steven | ||
700 | _aHolt, Shawn E. | ||
999 | _c22089 |